Ilyang Pharm (007570) — Net Asset Quality Index
Ilyang Pharm (007570) has a Net Asset Quality Index of 53.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩444.81 Billion minus total liabilities of ₩205.41 Billion yields net assets of ₩239.41 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Ilyang Pharm to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ilyang Pharm Net Asset Quality Index Over Time (2002–2024)
This chart shows how Ilyang Pharm's Net Asset Quality Index has evolved across 16 annual periods from 2002 to 2024. As of June 2025, the index stands at 53.8%, representing net assets of ₩239.41 Billion against total assets of ₩444.81 Billion KRW. See Ilyang Pharm current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ilyang Pharm (2002–2024)
The table below presents the year-by-year Net Asset Quality Index for Ilyang Pharm from 2002 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ilyang Pharm market cap and net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.0% | ₩241.58 Billion | ₩431.21 Billion | ₩189.63 Billion | ▲ +1.0 pp |
| 2023 | 55.1% | ₩196.41 Billion | ₩356.66 Billion | ₩160.25 Billion | ▼ -3.5 pp |
| 2022 | 58.6% | ₩291.85 Billion | ₩498.19 Billion | ₩206.33 Billion | ▲ +3.6 pp |
| 2021 | 55.0% | ₩271.76 Billion | ₩494.27 Billion | ₩222.51 Billion | ▼ -0.8 pp |
| 2020 | 55.8% | ₩244.92 Billion | ₩439.12 Billion | ₩194.19 Billion | ▲ +4.9 pp |
| 2019 | 50.9% | ₩222.74 Billion | ₩437.46 Billion | ₩214.72 Billion | ▲ +2.4 pp |
| 2018 | 48.6% | ₩209.88 Billion | ₩432.25 Billion | ₩222.37 Billion | ▲ +0.2 pp |
| 2017 | 48.3% | ₩210.98 Billion | ₩436.37 Billion | ₩225.39 Billion | ▼ -2.1 pp |
| 2016 | 50.4% | ₩217.35 Billion | ₩431.26 Billion | ₩213.91 Billion | ▲ +1.5 pp |
| 2015 | 48.9% | ₩211.00 Billion | ₩431.63 Billion | ₩220.62 Billion | ▲ +6.3 pp |
| 2014 | 42.6% | ₩183.46 Billion | ₩430.83 Billion | ₩247.37 Billion | ▼ -3.6 pp |
| 2013 | 46.2% | ₩183.88 Billion | ₩398.38 Billion | ₩214.50 Billion | ▲ +1.6 pp |
| 2009 | 44.6% | ₩129.19 Billion | ₩289.86 Billion | ₩160.67 Billion | ▲ +5.1 pp |
| 2004 | 39.5% | ₩75.20 Billion | ₩190.53 Billion | ₩115.33 Billion | ▼ -6.4 pp |
| 2003 | 45.8% | ₩77.13 Billion | ₩168.29 Billion | ₩91.16 Billion | ▲ +2.4 pp |
| 2002 | 43.4% | ₩75.67 Billion | ₩174.24 Billion | ₩98.56 Billion | — |